Cumberland Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 809.90 K | $3.43 M | 100.00% | 5.42% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 740.00 K | $3.13 M | 100.00% | 4.95% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 503.36 K | $2.13 M | -0.75% | 3.37% |
| VANGUARD GROUP INC | 05/09/2025 | 416.57 K | $1.76 M | 11.31% | 2.79% |
| DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 252.19 K | $1.07 M | -7.61% | 1.69% |
| J. GOLDMAN & CO LP | 05/15/2025 | 241.48 K | $1.02 M | 100.00% | 1.62% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 223.80 K | $946.67 K | 100.00% | 1.50% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 184.16 K | $778.98 K | 0.00% | 1.23% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 05/14/2025 | 153.81 K | $692.15 K | 100.00% | 1.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 150.00 K | $634.50 K | 100.00% | 1.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 99.09 K | $419.22 K | 33.36% | 0.66% |
| BANK OF NEW YORK MELLON CORP | 04/29/2025 | 72.51 K | $306.73 K | -3.66% | 0.49% |
| EAM INVESTORS, LLC | 05/13/2025 | 71.78 K | $303.61 K | 100.00% | 0.48% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 70.42 K | $297.87 K | 100.00% | 0.47% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 69.80 K | $295.25 K | 100.00% | 0.47% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 05/15/2025 | 50.00 K | $211.50 K | 100.00% | 0.33% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 49.14 K | $207.00 K | -73.89% | 0.33% |
| CITADEL ADVISORS LLC | 05/15/2025 | 35.00 K | $148.05 K | -3.85% | 0.23% |
| STATE STREET CORP | 05/15/2025 | 33.70 K | $142.55 K | 0.00% | 0.23% |
| BLACKROCK, INC. | 05/02/2025 | 32.66 K | $138.14 K | -23.30% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 28.94 K | $122.41 K | 100.00% | 0.19% |
| CITADEL ADVISORS LLC | 05/15/2025 | 25.81 K | $109.19 K | 100.00% | 0.17% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 22.76 K | $96.25 K | -39.56% | 0.15% |
| CENTIVA CAPITAL, LP | 05/15/2025 | 20.00 K | $84.60 K | 100.00% | 0.13% |
| CRESSET ASSET MANAGEMENT, LLC | 05/13/2025 | 19.98 K | $84.49 K | -10.33% | 0.13% |
| NORTHERN TRUST CORP | 05/13/2025 | 19.60 K | $82.92 K | 24.76% | 0.13% |
| SIMPLEX TRADING, LLC | 05/12/2025 | 19.10 K | $80.00 K | 100.00% | 0.13% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 17.90 K | $75.72 K | 100.00% | 0.12% |
| WILEY BROS.-AINTREE CAPITAL, LLC | 05/15/2025 | 11.00 K | $48.51 K | 100.00% | 0.07% |
| CITADEL ADVISORS LLC | 05/15/2025 | 6.80 K | $28.76 K | 100.00% | 0.05% |
| MORGAN STANLEY | 05/15/2025 | 2.66 K | $11.25 K | 0.00% | 0.02% |
| CENTIVA CAPITAL, LP | 05/15/2025 | 1.60 K | $6.77 K | 100.00% | 0.01% |
| CAPITAL ADVISORS, LTD. LLC | 04/15/2025 | 437 | $2.00 K | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/13/2025 | 250 | $1.06 K | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/15/2025 | 68 | $288 | 4.62% | 0.00% |
| JPMORGAN CHASE & CO | 05/12/2025 | 19 | $80 | 0.00% | 0.00% |
| HUNTINGTON NATIONAL BANK | 05/14/2025 | 1 | $4 | 0.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cumberland Pharmaceuticals Inc. institutional Ownership - FAQ's
During the previous two years, 46 institutional investors and hedge funds held shares of Cumberland Pharmaceuticals Inc.. The most heavily invested institutionals were:
MILLENNIUM MANAGEMENT LLC: 809,897
Ikarian Capital, LLC: 740,000
RENAISSANCE TECHNOLOGIES LLC: 503,363
VANGUARD GROUP INC: 416,569
DIMENSIONAL FUND ADVISORS LP: 252,189
J. Goldman & Co LP: 241,481
28.64% of Cumberland Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.85 M shares in the last 24 months. This purchase volume represents approximately $24.65 M in transactions.